A four-gene signature predicts survival and anti-CTLA4 immunotherapeutic responses based on immune classification of melanoma

Ying Mei et al. identify a four-gene tumor immune-relevant signature that predicts the overall survival of melanoma patients and their response to the CTLA4 antibody ipilimumab. This study suggests a potential utility of this four-gene signature in prognosis, risk assessment, and prediction of anti-...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ying Mei, Mei-Ju May Chen, Han Liang, Li Ma
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Biology (General) QH301-705.5
Acceso en línea:	https://doaj.org/article/fbcc56ff9b0345b58cd3dc909e49d8e4
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:fbcc56ff9b0345b58cd3dc909e49d8e4
record_format	dspace
spelling	oai:doaj.org-article:fbcc56ff9b0345b58cd3dc909e49d8e42021-12-02T13:24:24ZA four-gene signature predicts survival and anti-CTLA4 immunotherapeutic responses based on immune classification of melanoma10.1038/s42003-021-01911-x2399-3642https://doaj.org/article/fbcc56ff9b0345b58cd3dc909e49d8e42021-03-01T00:00:00Zhttps://doi.org/10.1038/s42003-021-01911-xhttps://doaj.org/toc/2399-3642Ying Mei et al. identify a four-gene tumor immune-relevant signature that predicts the overall survival of melanoma patients and their response to the CTLA4 antibody ipilimumab. This study suggests a potential utility of this four-gene signature in prognosis, risk assessment, and prediction of anti-CTLA4 response in melanoma patients.Ying MeiMei-Ju May ChenHan LiangLi MaNature PortfolioarticleBiology (General)QH301-705.5ENCommunications Biology, Vol 4, Iss 1, Pp 1-12 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Biology (General) QH301-705.5
spellingShingle	Biology (General) QH301-705.5 Ying Mei Mei-Ju May Chen Han Liang Li Ma A four-gene signature predicts survival and anti-CTLA4 immunotherapeutic responses based on immune classification of melanoma
description	Ying Mei et al. identify a four-gene tumor immune-relevant signature that predicts the overall survival of melanoma patients and their response to the CTLA4 antibody ipilimumab. This study suggests a potential utility of this four-gene signature in prognosis, risk assessment, and prediction of anti-CTLA4 response in melanoma patients.
format	article
author	Ying Mei Mei-Ju May Chen Han Liang Li Ma
author_facet	Ying Mei Mei-Ju May Chen Han Liang Li Ma
author_sort	Ying Mei
title	A four-gene signature predicts survival and anti-CTLA4 immunotherapeutic responses based on immune classification of melanoma
title_short	A four-gene signature predicts survival and anti-CTLA4 immunotherapeutic responses based on immune classification of melanoma
title_full	A four-gene signature predicts survival and anti-CTLA4 immunotherapeutic responses based on immune classification of melanoma
title_fullStr	A four-gene signature predicts survival and anti-CTLA4 immunotherapeutic responses based on immune classification of melanoma
title_full_unstemmed	A four-gene signature predicts survival and anti-CTLA4 immunotherapeutic responses based on immune classification of melanoma
title_sort	four-gene signature predicts survival and anti-ctla4 immunotherapeutic responses based on immune classification of melanoma
publisher	Nature Portfolio
publishDate	2021
url	https://doaj.org/article/fbcc56ff9b0345b58cd3dc909e49d8e4
work_keys_str_mv	AT yingmei afourgenesignaturepredictssurvivalandantictla4immunotherapeuticresponsesbasedonimmuneclassificationofmelanoma AT meijumaychen afourgenesignaturepredictssurvivalandantictla4immunotherapeuticresponsesbasedonimmuneclassificationofmelanoma AT hanliang afourgenesignaturepredictssurvivalandantictla4immunotherapeuticresponsesbasedonimmuneclassificationofmelanoma AT lima afourgenesignaturepredictssurvivalandantictla4immunotherapeuticresponsesbasedonimmuneclassificationofmelanoma AT yingmei fourgenesignaturepredictssurvivalandantictla4immunotherapeuticresponsesbasedonimmuneclassificationofmelanoma AT meijumaychen fourgenesignaturepredictssurvivalandantictla4immunotherapeuticresponsesbasedonimmuneclassificationofmelanoma AT hanliang fourgenesignaturepredictssurvivalandantictla4immunotherapeuticresponsesbasedonimmuneclassificationofmelanoma AT lima fourgenesignaturepredictssurvivalandantictla4immunotherapeuticresponsesbasedonimmuneclassificationofmelanoma
_version_	1718393129974890496

A four-gene signature predicts survival and anti-CTLA4 immunotherapeutic responses based on immune classification of melanoma

Ejemplares similares